Use of human chorionic gonadotropin in the treatment of...

Details Use of human chorionic gonadotropin in the treatment of... Use of human chorionic gonadotropin in the treatment of...

A - Human Necessities

61

K

A61K 38/24 (2006.01)

Patent

CA 2243948

The use of hCG Beta-core or hCG fragments, deglycosylated hCG in the treatment of Kaposi's sarcoma is described. Inhibition of tumour production or regression on a variety of KS cell lines is shown. Purified hCG preparations do not inhibit the growth of KS cell lines.

On décrit l'utilisation du noyau bêta de hCG (gonadotrophine chorionique humaine) ou de fragments de hCG, ou de hCG déglycosylé, dans le traitement du sarcome de Kaposi. On démontre l'inhibition de la production tumorale ou la régression sur plusieurs lignées cellulaires du sarcome de Kaposi. Des préparations de hCG purifiées n'inhibent pas la croissance des lignées cellulaires du sarcome de Kaposi.

Affiliated with

Also associated with

Rating

Use of human chorionic gonadotropin in the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of human chorionic gonadotropin in the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of human chorionic gonadotropin in the treatment of... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1581773